Hasil Pencarian - Yolanda van der Graaf
- Menampilkan 1 - 20 hasil dari 24
- Ke Halaman Berikutnya
-
1
Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled cros... oleh Charlotte Koopal, A. David Marais, Jan Westerink, Yolanda van der Graaf, Frank L.J. Visseren
Diterbitkan 2017-11-01
Artikel -
2
-
3
-
4
Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective? oleh Gijs F. N. Berkelmans, Jacoba P. Greving, Yolanda van der Graaf, Frank L. J. Visseren, Jannick A. N. Dorresteijn
Diterbitkan 2020-04-01
Artikel -
5
Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients oleh Manon C. Stam‐Slob, Yolanda van der Graaf, Jacoba P. Greving, Jannick A.N. Dorresteijn, Frank L.J. Visseren
Diterbitkan 2017-02-01
Artikel -
6
Direct short-term effects of EBP teaching: change in knowledge, not in attitude; a cross-cultural comparison among students from European and Asian medical schools oleh Indah S. Widyahening, Geert J.M.G. van der Heijden, Foong Ming Moy, Yolanda van der Graaf, Sudigdo Sastroasmoro, Awang Bulgiba
Diterbitkan 2012-10-01
Artikel -
7
Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study oleh Anne M. Grool, Yolanda van der Graaf, Theo D. Witkamp, Koen L. Vincken, Willem P. T. M. Mali, Mirjam I. Geerlings
Diterbitkan 2011-01-01
Artikel -
8
Impact of a Patient’s Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision Making oleh Tamar I. de Vries, Manon C. Stam‐Slob, Ron J. G. Peters, Yolanda van der Graaf, Jan Westerink, Frank L. J. Visseren
Diterbitkan 2022-01-01
Artikel -
9
Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension oleh Monique E. A. M. van Kleef, Frank L. J. Visseren, Jan Westerink, Michiel L. Bots, Peter J. Blankestijn, Yolanda van der Graaf, Wilko Spiering
Diterbitkan 2020-04-01
Artikel -
10
Intra and interobserver reliability and agreement of semiquantitative vertebral fracture assessment on chest computed tomography. oleh Constantinus F Buckens, Pim A de Jong, Christian Mol, Eric Bakker, Hein P Stallman, Willem P Mali, Yolanda van der Graaf, Helena M Verkooijen
Diterbitkan 2013-01-01
Artikel -
11
Multifocal cardiovascular calcification in patients with established cardiovascular disease; prevalence, risk factors, and relation with recurrent cardiovascular disease oleh Cilie C. van 't Klooster, Hendrik M. Nathoe, J. Hjortnaes, Michiel L. Bots, Ivana Isgum, Nikolas Lessmann, Yolanda van der Graaf, Tim Leiner, Frank L.J. Visseren
Diterbitkan 2020-04-01
Artikel -
12
The diagnostic value of clinical symptoms in women and men presenting with chest pain at the emergency department, a prospective cohort study. oleh Manon G van der Meer, Barbra E Backus, Yolanda van der Graaf, Maarten J Cramer, Yolande Appelman, Pieter A Doevendans, A Jacob Six, Hendrik M Nathoe
Diterbitkan 2015-01-01
Artikel -
13
Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease. oleh Anton P van de Woestijne, Yolanda van der Graaf, Paul I W de Bakker, Folkert W Asselbergs, Wilko Spiering, Frank L J Visseren, SMART Study Group
Diterbitkan 2014-01-01
Artikel -
14
-
15
Association between subcortical vascular lesion location and cognition: a voxel-based and tract-based lesion-symptom mapping study. The SMART-MR study. oleh J Matthijs Biesbroek, Hugo J Kuijf, Yolanda van der Graaf, Koen L Vincken, Albert Postma, Willem P T M Mali, Geert J Biessels, Mirjam I Geerlings, SMART Study Group
Diterbitkan 2013-01-01
Artikel -
16
Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled... oleh Yvo M Smulders, Guy E H M Rutten, Frank L J Visseren, Yolanda van der Graaf, Olga C Damman, Nicole E M Jaspers, Jannick A N Dorresteijn, Corline Brouwers
Diterbitkan 2021-07-01
Artikel -
17
Impact of cardiovascular calcifications on the detrimental effect of continued smoking on cardiovascular risk in male lung cancer screening participants. oleh Pushpa M Jairam, Pim A de Jong, Willem P T h M Mali, Ivana Isgum, Harry J de Koning, Carlijn van der Aalst, Matthijs Oudkerk, Rozemarijn Vliegenthart, Yolanda van der Graaf
Diterbitkan 2013-01-01
Artikel -
18
Physical Activity and Characteristics of the Carotid Artery Wall in High‐Risk Patients—The SMART (Second Manifestations of Arterial Disease) Study oleh H. Myrthe Boss, Yolanda van der Graaf, Frank L. J. Visseren, Renske M. Van den Berg‐Vos, Michiel L. Bots, Gert Jan de Borst, Maarten J. Cramer, L. Jaap Kappelle, Mirjam I. Geerlings
Diterbitkan 2017-07-01
Artikel -
19
Reliability of visual assessment of non-contrast CT, CT angiography source images and CT perfusion in patients with suspected ischemic stroke. oleh Tom van Seeters, Geert Jan Biessels, Joris M Niesten, Irene C van der Schaaf, Jan Willem Dankbaar, Alexander D Horsch, Willem P T M Mali, L Jaap Kappelle, Yolanda van der Graaf, Birgitta K Velthuis, Dust Investigators
Diterbitkan 2013-01-01
Artikel -
20
Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model oleh Lotte Kaasenbrood, Deepak L. Bhatt, Jannick A.N. Dorresteijn, Peter W.F. Wilson, Ralph B. D'Agostino, Joseph M. Massaro, Yolanda van der Graaf, Maarten J.M. Cramer, L. Jaap Kappelle, Gert J. de Borst, Ph. Gabriel Steg, Frank L. J. Visseren
Diterbitkan 2018-08-01
Artikel